Cargando…
Sustained Endothelial Expression of HoxA5 In Vivo Impairs Pathological Angiogenesis And Tumor Progression
HoxA5 is expressed in quiescent endothelial cells (EC), but absent in activated angiogenic EC. To examine the efficacy of targeting HoxA5 therapeutically to quell pathologic or tumor angiogenesis, we generated an inducible, transgenic mouse model of sustained HoxA5 expression in ECs. During patholog...
Autores principales: | Cuevas, Ileana, Layman, Hans, Coussens, Lisa, Boudreau, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379087/ https://www.ncbi.nlm.nih.gov/pubmed/25821967 http://dx.doi.org/10.1371/journal.pone.0121720 |
Ejemplares similares
-
Correction: Sustained Endothelial Expression of HoxA5 In Vivo Impairs Pathological Angiogenesis And Tumor Progression
por: Cuevas, Ileana, et al.
Publicado: (2016) -
Hox in motion: tracking HoxA cluster conformation during differentiation
por: Rousseau, Mathieu, et al.
Publicado: (2014) -
The role of HoxA11 and HoxA13 in the evolution of novel fin morphologies in a representative batoid (Leucoraja erinacea)
por: Barry, Shannon N., et al.
Publicado: (2017) -
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020) -
HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia
por: Brumatti, Gabriela, et al.
Publicado: (2013)